Le H Hua

15PUBLICATIONS
65CO-AUTHORS
Predictive and prognostic markersMedical infection agents (incl. prions)Medical genetics (excl. cancer genetics)Regenerative medicine (incl. stem cells)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 30, 2026
Early Versus Delayed Treatment with Ocrelizumab: A Multicenter, Real-World Observational Study in People with Multiple Sclerosis.

|May 14, 2026
Long-term follow-up of patients with multiple sclerosis over age 60: Comparing clinical and radiological outcomes in disease-modifying therapy continuers and discontinuers.

|Feb 18, 2026
Comparative Effectiveness and Risk of Severe Infection in Adult Patients With MS Treated With Diroximel Fumarate Versus Anti-CD20 Monoclonal Antibodies: A Real-World Claims Analysis.

Ahmed Z Obeidat, Michelle Betz, Rebecca Straus Farber

|Dec 10, 2025
Management of Functional Seizures Practice Guideline Executive Summary: Report of the AAN Guidelines Subcommittee.

Benjamin Tolchin, Laura H Goldstein, Markus Reuber

|Nov 06, 2025
Switch from intravenous anti-CD20 therapy to subcutaneous ofatumumab in patients with relapsing MS: results from the OLIKOS study.

Le H Hua, Brandon Brown, Elizabeth Camacho

|Jul 15, 2025
Outcomes of older patients with multiple sclerosis treated with interferon beta-1a or peginterferon beta-1a in MS PATHS.

Le H Hua, Carrie M Hersh, Lana Zhovtis Ryerson

Pageof 3

Frequent Collaborators

3 joint publications

Daniel Ontaneda

2 joint publications

Devon S Conway

2 joint publications

Kunio Nakamura

2 joint publications

Jeffrey A Cohen